%  LaTeX support: latex@publication.uz
%  For support, please attach all files needed for compiling as well as the log file, and specify your operating system, LaTeX version, and LaTeX editor.

%=================================================================
\documentclass[i-edu.uz,journal,article,submit,pdftex,moreauthors]{Definitions/i-edu.uz} 
\usepackage[T2A]{fontenc}
\usepackage[utf8]{inputenc} % If you're using UTF-8 encoding
\usepackage[Uzbek]{babel}
\usepackage{tempora} % Or any other suitable font package

%---------
% article
%---------
% The default type of manuscript is "article", but can be replaced by: 
% аннотации, приложение, статья, книга, рецензия на книгу, краткий отчет, отчет о случае, комментарий, комментарий, сообщение, материалы конференции, исправление, отчет о конференции, запись, выражение озабоченности, расширенный реферат, дескриптор данных, редакционная статья, эссе, опечатка, гипотеза, интересное изображение, некролог, мнение, отчет о проекте , ответ, опровержение, обзор, перспектива, протокол, короткая заметка, протокол исследования, систематический обзор, файл поддержки, техническая заметка, точка зрения, рекомендации, зарегистрированный отчет, руководство
% supfile = supplementary materials

%----------
% submit
%----------
% Опция класса «отправить» будет изменена редакцией на «принять», когда статья будет принята. Это приведет к изменению только главной страницы (например, станет виден логотип журнала), заголовков и информации об авторских правах. Также будет удалена нумерация строк. Информация о журнале и нумерация страниц для принятых статей также определяются редакцией.

%------------------
% moreauthors
%------------------
% Если имеется только один автор, следует использовать опцию класса oneauthor. В противном случае используйте опцию класса moreauthors.

%---------
% pdftex
%---------
% Опция pdftex предназначена для использования с pdfLaTeX. Удалите «pdftex» для (1) компиляции с помощью LaTeX и dvi2pdf (если используются рисунки в формате EPS) или для (2) компиляции с XeLaTeX.

%=================================================================
% Publication.UZ internal commands - do not modify
\firstpage{1} 
\makeatletter 
\setcounter{page}{\@firstpage} 
\makeatother
\pubvolume{1}
\issuenum{1}
\articlenumber{1}
\pubyear{2026}
\copyrightyear{2026}
%\externaleditor{Academic Editor: Firstname Lastname}
\datereceived{10.02.2026 } 
\daterevised{18.01.2026} % Comment out if no revised date
\dateaccepted{25.01.2026} 
\datepublished{30.01.2026} 
%\datecorrected{} % For corrected papers: "Corrected: XXX" date in the original paper.
%\dateretracted{} % For corrected papers: "Retracted: XXX" date in the original paper.
\hreflink{https://doi.org/10.00000/Problems-of-Mechanics-2026-3-00000} % If needed use \linebreak
%\doinum{}
%\pdfoutput=1 % Uncommented for upload to arXiv.org
%\CorrStatement{yes}  % For updates


%=================================================================
% Add packages and commands here. The following packages are loaded in our class file: fontenc, inputenc, calc, indentfirst, fancyhdr, graphicx, epstopdf, lastpage, ifthen, float, amsmath, amssymb, lineno, setspace, enumitem, mathpazo, booktabs, titlesec, etoolbox, tabto, xcolor, colortbl, soul, multirow, microtype, tikz, totcount, changepage, attrib, upgreek, array, tabularx, pbox, ragged2e, tocloft, marginnote, marginfix, enotez, amsthm, natbib, hyperref, cleveref, scrextend, url, geometry, newfloat, caption, draftwatermark, seqsplit, russian
% cleveref: load \crefname definitions after \begin{document}

%=================================================================
% Please use the following mathematics environments: Theorem, Lemma, Corollary, Proposition, Characterization, Property, Problem, Example, ExamplesandDefinitions, Hypothesis, Remark, Definition, Notation, Assumption
%% For proofs, please use the proof environment (the amsthm package is loaded by the Publication.UZ class).

%=================================================================
% Full title of the paper (Capitalized)
\Title{\textbf{Nomi: {\Large Qo‘lyozmangizning nomi qisqa, aniq va dolzarb bo‘lishi kerak. Iltimos, sarlavha yoki qisqa shakllar kabi qisqartirilgan nomlarni kiritmang. Ular bizning tahririyat tomonidan olib tashlanadi.}}}

% Publication.UZ internal command: Title for citation in the left column
\TitleCitation{Acta Education}


% Author Orchid ID: enter ID or remove command
\newcommand{\orcidauthorA}{0000-0000-0000-0000}
\newcommand{\orcidauthorS}{0000-0000-0000-0000}
\newcommand{\orcidauthorD}{0000-0000-0000-0000}
\newcommand{\orcidauthorG}{0000-0000-0000-0000}  % Add \orcidA{} behind the author's name
%\newcommand{\orcidauthorB}{0000-0000-0000-000X} % Add \orcidB{} behind the author's name

% Authors, for the paper (add full first names)
\Author{Muallif (I.O. Familiya) $^{1}$ \orcidA{}, Muallif (I.O. Familiya) $^{1}$\orcidS{}, Muallif (I.O. Familiya) $^{1}$* \orcidD{}, Muallif (I.O. Familiya) $^{1}$\orcidG{}}

%\longauthorlist{yes}

% Publication.UZ internal command: Authors, for metadata in PDF
\AuthorNames{Muallif (I.O. Familiya),Muallif (I.O. Familiya), Muallif (I.O. Familiya), Muallif (I.O. Familiya)}

% Publication.UZ internal command: Authors, for citation in the left column
\AuthorCitation{Muallif (I.O. Familiya), Muallif (I.O. Familiya), Muallif (I.O. Familiya),Muallif (I.O. Familiya)}
% If this is a Chicago style journal: Lastname, Firstname, Firstname Lastname, and Firstname Lastname.

% Affiliations / Addresses (Add [1] after \address if there is only one affiliation.)
\address{%
$^{1}$ \quad Bo‘lim nomi, Tashkilot nomi, Shahar, indeks, Mamlakat\\

$^{}$ \quad e-mail@e-mail.com (I.F.), e-mail@e-mail.com (I.F.), e-mail@e-mail.com (I.F.)\\
}

% Contact information of the corresponding author
\corres{Correspondence: e-mail@e-mail.com; Tel.: +000 00 0000000 (И.Ф.)}

%\simplesumm{} % Simple summary

%\conference{} % An extended version of a conference paper

%\Abstract (Do not insert blank lines, i.e. \\) 

\abstract {Annotatsiya umumiy hisobda 200 so‘zdan ko‘p bo‘lmasligi kerak. Ilmiy maqolalar uchun annotatsiya ishning qisqa sharhini taqdim etishi kerak. Mualliflarga tuzilgan annotatsiyalar uslubidan foydalanishni qat’iy tavsiya qilamiz, ammo sarlavhasiz.\\
\textbf{Maqsad.} Ilmiy maqolada maqsad asosiy tadqiqot vazifasini aniq ifoda etishi kerak, ya’ni mualliflar nimaga erishish yoki o‘rganishga intilayotganini belgilab berishi kerak. U qisqa, tushunarli va ishning asosiy yo‘nalishini aks ettirishi kerak.
\newline\textbf{Materiallar va usullar}. Tadqiqotda qo‘llanilgan asosiy usullar yoki yondashuvlarni qisqacha tavsiflang.
\newline\textbf{Natijalar}. Maqolaning asosiy natijalarini qisqacha bayon qiling.
\newline\textbf{Xulosa}. Asosiy xulosalar yoki talqinlarni ko‘rsating. Annotatsiya maqolaning mazmunini ob'ektiv ravishda aks ettirishi kerak, asosiy matnda taqdim etilmagan va asoslanmagan natijalarni o‘z ichiga olmasligi va asosiy xulosalarni ortiqcha ko‘paytirmasligi kerak.
}

% Keywords
\keyword{Annotatsiyadan so‘ng uchtadan o‘ntagacha tegishli kalit so‘zlarni qo‘shish zarur. Kalit so‘zlar maqolaning mazmuniga muvofiq bo‘lishi va sohaviy soha doirasida keng tarqalgan terminlar bo‘lishi tavsiya etiladi.} \\

% The fields PACS, MSC, and JEL may be left empty or commented out if not applicable
%\PACS{J0101}
%\MSC{}
%\JEL{}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Only for the journal Diversity
%\LSID{\url{http://}}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Only for the journal Applied Sciences
%\featuredapplication{Authors are encouraged to provide a concise description of the specific application or a potential application of the work. This section is not mandatory.}
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Only for the journal Data
%\dataset{DOI number or link to the deposited data set if the data set is published separately. If the data set shall be published as a supplement to this paper, this field will be filled by the journal editors. In this case, please submit the data set as a supplement.}
%\datasetlicense{License under which the data set is made available (CC0, CC-BY, CC-BY-SA, CC-BY-NC, etc.)}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Only for the journal Toxins
%\keycontribution{The breakthroughs or highlights of the manuscript. Authors can write one or two sentences to describe the most important part of the paper.}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Only for the journal Encyclopedia
%\encyclopediadef{For entry manuscripts only: please provide a brief overview of the entry title instead of an abstract.}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Only for the journal Advances in Respiratory Medicine
%\addhighlights{yes}
%\renewcommand{\addhighlights}{%

%\noindent This is an obligatory section in “Advances in Respiratory Medicine”, whose goal is to increase the discoverability and readability of the article via search engines and other scholars. Highlights should not be a copy of the abstract, but a simple text allowing the reader to quickly and simplified find out what the article is about and what can be cited from it. Each of these parts should be devoted up to 2~bullet points.\vspace{3pt}\\
%\textbf{What are the main findings?}
% \begin{itemize}[labelsep=2.5mm,topsep=-3pt]
% \item First bullet.
% \item Second bullet.
% \end{itemize}\vspace{3pt}
%\textbf{What is the implication of the main finding?}
% \begin{itemize}[labelsep=2.5mm,topsep=-3pt]
% \item First bullet.
% \item Second bullet.
% \end{itemize}
%}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\begin{document}
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\begin{sloppypar}

\noindent{\textbf{Title: {\large The title of your manuscript should be concise, specific and relevant. It should identify if the study reports (human or animal) trial data, or is a systematic review, meta-analysis or replication study. Please do not include abbreviated or short forms of the title, such as a running title or head. These will be removed by our Editorial Office.}}}

\begingroup
\raggedright 

 \textbf{Name I.Surname}  $^{1}$ \orcidA{}, \textbf{Name I.Surname}  $^{1}$\orcidS{}, \textbf{Name I.Surname}  $^{1}$* \orcidD{}, \textbf{Name I.Surname}  $^{1}$\orcidG{}
\endgroup\\

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\noindent {\scriptsize{\\ \noindent$^{1}$ \quad Department Name, Organization Name, City, ZIP Code, Country

\noindent$^{}$ \quad e-mail@e-mail.com (F.L.,), e-mail@e-mail.com (F.L.,), e-mail@e-mail.com (F.L.,),e-mail@e-mail.com (F.L.,))}}\\

\noindent\textbf{Abstract:}\\A single paragraph of about 200 words maximum. For research articles, abstracts should give a pertinent overview of the work. We strongly encourage authors to use the following style of structured abstracts, but without headings:
\\
\textbf{Background.} place the question addressed in a broad context and highlight the purpose of the study;

\noindent\textbf{Materials and methods.} describe briefly the main methods or treatments applied; 

\noindent\textbf{Results.}summarize the article's main findings;

\noindent\textbf{Conclusion.} indicate the main conclusions or interpretations. The abstract should be an objective representation of the article, it must not contain results which are not presented and substantiated in the main text and should not exaggerate the main conclusions.\\

\noindent\textbf{Keywords:} keyword 1; keyword 2; keyword 3 (List three to ten pertinent keywords specific to the article; yet reasonably common within the subject discipline.)

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\setcounter{section}{-0} %% Remove this when starting to work on the template.

\section{Kirish}

Kirish qisqacha tadqiqotni keng kontekstda taqdim etishi va uning ahamiyatini ta'kidlishi kerak. Ishning maqsadi va ahamiyati aniq belgilanishi zarur. Tadqiqot sohasidagi hozirgi vaziyatning diqqat bilan ko‘rib chiqilishi va asosiy nashrlarga ishora qilinishi kerak. Agar kerak bo‘lsa, zidiyatli va muqobil gipotezalarni ajratish zarur. Oxirida, ishning asosiy maqsadini qisqacha ta'riflab, asosiy xulosalarni ta'kidlang. Iloji boricha kirishni sizning maxsus sohangizdan tashqari bo‘lgan olimlar uchun tushunarli qilishga harakat qiling. Ma'lumotlar uchun maqolaga ishora \cite{ref-journal}. Kitobga ishora \cite{ref-book1,ref-book2} yoki boshqa turdagi ishoralar \cite{ref-unpublish,ref-communication,ref-proceeding}



%\endnote{This is an endnote.} % To use endnotes, please un-comment \printendnotes below (before References). Only journal Laws uses \footnote.

% The order of the section titles is different for some journals. Please refer to the "Instructions for Authors” on the journal homepage.

\section{Materiallar va usullar}

 Tavsif yetarlicha batafsil bo‘lishi kerak, shunda boshqalar natijalarni qayta tiklash va nashr qilingan natijalarga tayangan holda ishlashlari mumkin. E'tibor bering, qo‘lyozmangizning nashri sizning barcha o‘quvchilarga barcha materiallar, ma'lumotlar, dasturiy kodlar va protokollarga kirish imkoniyatini taqdim etishni anglatadi. Ilova qilish bosqichida materiallar yoki ma'lumotlarga kirishdagi cheklovlarni ko‘rsating. Yangi usullar va protokollar batafsil tavsiflanishi kerak, yaxshi o‘rnatilgan usullar esa qisqacha tavsiflanishi va tegishli havolalar bilan ta'minlanishi mumkin.

"Tadqiqotlarning qo‘lyozmalari, katta ma'lumotlar to‘plamlari haqidagi xabarlar, ommaviy ma'lumot bazalarida joylashtirilgan bo‘lsa, ma'lumotlarning qayerda joylashtirilganligini va tegishli kirish raqamlarini ko‘rsatishi kerak. Agar kirish raqamlari topshirish vaqtida hali olinmagan bo‘lsa, ular sharh jarayonida taqdim etilishini ko‘rsating. Raqamlar nashr qilishdan oldin taqdim etilishi kerak.

Hayvonlar yoki odamlar bilan o‘tkazilgan aralashuv tadqiqotlari va boshqa etik tasdiqlashni talab qiladigan tadqiqotlar, tasdiqlashni bergan organ haqidagi ma'lumotni va tegishli etik kodni ko‘rsatishi kerak.

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\section{Natijalar}

Ushbu bo‘lim bo‘limlarga bo‘linishi mumkin. U tajriba natijalarini qisqacha va aniq tavsiflash, ularning talqinini hamda tajribadan chiqarilgan xulosalarni o‘z ichiga olishi kerak.

\subsection{Bo‘lim}
\subsubsection{Qo‘shimcha bo‘lim}

Belgilangan ro‘yxatlar quyidagicha ko‘rinadi:
\begin{itemize}
\item Birinchi  bo‘lim;
\item Ikkinchi  bo‘lim;
\item Uchinchi  bo‘lim.
\end{itemize}

Raqamlangan ro‘yxatlar quyidagicha qo‘shilishi mumkin:
\begin{enumerate}
\item Birinchi  bo‘lim;
\item Ikkinchi  bo‘lim;
\item Uchinchi  bo‘lim.
\end{enumerate}

Matn shu yerda davom etadi.

\subsection{Rasmlar, jadvallar va sxemalar}

Barcha rasm va jadvallar asosiy matnda Rasm~\ref{fig1}, Jadval~\ref{tab1} va hokazo tarzda keltirilishi kerak.

\begin{figure}[H]
\includegraphics[width=10.5 cm]{issledovania.jpg}

\caption{\centering Bu rasm.\\ Sxemalarni shunga o‘xshash qoidalar bo‘yicha tayyorlash kerak. Agar rasmda bir nechta panellar bo‘lsa, ularni quyidagicha sanab o‘ting: (\textbf{a}) Birinchi panelning mazmuni tavsifi. (\textbf{b}) Ikkinchi panelning mazmuni tavsifi. Rasmlar asosiy matnda birinchi eslatilgan joyga yaqin joylashtirilishi kerak. Yozuv markazga joylashtirilishi va bir qatorda bo‘lishi kerak.\\
Rasm.1. Bu rasm.

\label{fig1}}
\end{figure}   
\unskip

\begin{table}[H] 
\caption{This is the record of the table.\\ 
\textbf{Jadval 1.} Bu jadvalning yozuvi. Jadvallar asosiy matnda birinchi eslatilgan joyga yaqin joylashtirilishi kerak.\label{tab1}
}
\newcolumntype{C}{>{\centering\arraybackslash}X}
\begin{tabularx}{\textwidth}{CCC}
\toprule
\textbf{Title 1}	& \textbf{Title 2}	& \textbf{Title 3}\\
\midrule
Entry 1		& Data			& Data\\
Entry 2		& Data			& Data \textsuperscript{1}\\
\bottomrule
\end{tabularx}
\noindent{\footnotesize{\textsuperscript{1} Jadvallar pastki izohni o‘z ichiga olishi mumkin.}}
\end{table}

Matn shu yerda davom etadi (Rasm~\ref{fig2} va Jadval~\ref{tab2}).

% Example of a figure that spans the whole page width. The same concept works for tables, too.
\begin{figure}[H]
\begin{adjustwidth}{-\extralength}{0cm}
\centering
\includegraphics[width=15.5cm]{issledovania.jpg}
\end{adjustwidth}
\caption{This is a wide picture.\\
\textbf{Fig.2.}Bu keng rasm.\label(fig2}
\end{figure}  

\begin{table}[H] 
\caption{This is the record of the table.\\ 
\textbf{Jadval 1.} Bu jadvalning yozuvi\label{tab2}
}
	\begin{adjustwidth}{-\extralength}{0cm}
		\newcolumntype{C}{>{\centering\arraybackslash}X}
		\begin{tabularx}{\fulllength}{CCCC}
			\toprule
			\textbf{Title 1}	& \textbf{Title 2}	& \textbf{Title 3}     & \textbf{Title 4}\\
			\midrule
\multirow[m]{3}{*}{Entry 1 *}	& Data			& Data			& Data\\
			  	                   & Data			& Data			& Data\\
			             	      & Data			& Data			& Data\\
                   \midrule
\multirow[m]{3}{*}{Entry 2}    & Data			& Data			& Data\\
			  	                  & Data			& Data			& Data\\
			             	     & Data			& Data			& Data\\
                   \midrule
\multirow[m]{3}{*}{Entry 3}    & Data			& Data			& Data\\
			  	                 & Data			& Data			& Data\\
			             	    & Data			& Data			& Data\\
                  \midrule
\multirow[m]{3}{*}{Entry 4}   & Data			& Data			& Data\\
			  	                 & Data			& Data			& Data\\
			             	    & Data			& Data			& Data\\
			\bottomrule
		\end{tabularx}
	\end{adjustwidth}
	\noindent{\footnotesize{* Jadvallar pastki izohni o‘z ichiga olishi mumkin.}}
\end{table}

%\begin{listing}[H]
%\caption{Title of the listing}
%\rule{\columnwidth}{1pt}
%\raggedright Text of the listing. In font size footnotesize, small, or normalsize. Preferred format: left aligned and single spaced. Preferred border format: top border line and bottom border line.
%\rule{\columnwidth}{1pt}
%\end{listing}

Matn.

Matn.

\subsection{Matematik komponentlarni formatlash}

Bu misol tenglama 1:
\begin{linenomath}
\begin{equation}
a = 1,
\end{equation}
\end{linenomath}
Matematik komponentlarni formatlash Tenglamadan keyingi matn yangi paragrafdan boshlanishi shart emas. Iltimos, tenglamalarda punktuatsiyani odatiy matn kabi qo‘ying.
%% If the documentclass option "submit" is chosen, please insert a blank line before and after any math environment (equation and eqnarray environments). This ensures correct linenumbering. The blank line should be removed when the documentclass option is changed to "accept" because the text following an equation should not be a new paragraph.

Bu misol tenglama 2:
\begin{adjustwidth}{-\extralength}{0cm}
\begin{equation}
a = b + c + d + e + f + g + h + i + j + k + l + m + n + o + p + q + r + s + t + u + v + w + x + y + z
\end{equation}
\end{adjustwidth}

% Example of a page in landscape format (with table and table footnote).
%\startlandscape
%\begin{table}[H] %% Table in wide page
%\caption{This is a very wide table.\label{tab3}}
%	\begin{tabularx}{\textwidth}{CCCC}
%		\toprule
%		\textbf{Title 1}	& \textbf{Title 2}	& \textbf{Title 3}	& \textbf{Title 4}\\
%		\midrule
%		Entry 1		& Data			& Data			& This cell has some longer content that runs over two lines.\\
%		Entry 2		& Data			& Data			& Data\textsuperscript{1}\\
%		\bottomrule
%	\end{tabularx}
%	\begin{adjustwidth}{+\extralength}{0cm}
%		\noindent\footnotesize{\textsuperscript{1} This is a table footnote.}
%	\end{adjustwidth}
%\end{table}
%\finishlandscape


Iltimos, tenglamalarda punktuatsiyani odatiy matn kabi qo‘ying. Teorema turidagi muhitlarni (takliflar, lemma, natijalar va boshqalar) quyidagicha formatlash mumkin:

%% Teorema misoli:
\begin{Theorem} \textbf{Teorema} 

Teoremaning matn misoli.
\end{Theorem}

Matn shu yerda davom etadi. Isbotlar quyidagicha formatlanishi kerak:

%% Example of a proof:
\begin{Theorem} \textbf{Teorema 1}

Isbot matni. E'tibor bering, "teorema 1" iborasi, agar qaysi teorema haqida gapirilayotganligi aniq bo'lsa, majburiy emas.
\end{Theorem}

Matn shu yerda davom etadi.\\

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\section{Munozara}

Mualliflar natijalarni va ularning talqinini oldingi tadqiqotlar va ish gipotezasi kontekstida muhokama qilishlari kerak. Topilmalar va ularning oqibatlarini eng keng kontekstdagi muhokama qilish zarur. Shuningdek, kelajakdagi tadqiqotlar uchun yo‘nalishlarni ajratish mumkin.

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\vspace{6pt} 

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% optional
%\supplementary{The following supporting information can be downloaded at:  \linksupplementary{s1}, Figure S1: title; Table S1: title; Video S1: title.}

% Only for journal Methods and Protocols:
% If you wish to submit a video article, please do so with any other supplementary material.
% \supplementary{The following supporting information can be downloaded at: \linksupplementary{s1}, Figure S1: title; Table S1: title; Video S1: title. A supporting video article is available at doi: link.}

% Only for journal Hardware:
% If you wish to submit a video article, please do so with any other supplementary material.
% \supplementary{The following supporting information can be downloaded at: \linksupplementary{s1}, Figure S1: title; Table S1: title; Video S1: title.\vspace{6pt}\\
%\begin{tabularx}{\textwidth}{lll}
%\toprule
%\textbf{Name} & \textbf{Type} & \textbf{Description} \\
%\midrule
%S1 & Python script (.py) & Script of python source code used in XX \\
%S2 & Text (.txt) & Script of modelling code used to make Figure X \\
%S3 & Text (.txt) & Raw data from experiment X \\
%S4 & Video (.mp4) & Video demonstrating the hardware in use \\
%... & ... & ... \\
%\bottomrule
%\end{tabularx}
%}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\section{Xulosa}

Ushbu bo‘lim majburiy emas, ammo agar muhokama ayniqsa uzun yoki murakkab bo‘lsa, qo‘lyozmaga qo‘shilishi mumkin.

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\vspace{6pt} 

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% optional
%\supplementary{The following supporting information can be downloaded at:  \linksupplementary{s1}, Figure S1: title; Table S1: title; Video S1: title.}

% Only for journal Methods and Protocols:
% If you wish to submit a video article, please do so with any other supplementary material.
% \supplementary{The following supporting information can be downloaded at: \linksupplementary{s1}, Figure S1: title; Table S1: title; Video S1: title. A supporting video article is available at doi: link.}

% Only for journal Hardware:
% If you wish to submit a video article, please do so with any other supplementary material.
% \supplementary{The following supporting information can be downloaded at: \linksupplementary{s1}, Figure S1: title; Table S1: title; Video S1: title.\vspace{6pt}\\
%\begin{tabularx}{\textwidth}{lll}
%\toprule
%\textbf{Name} & \textbf{Type} & \textbf{Description} \\
%\midrule
%S1 & Python script (.py) & Script of python source code used in XX \\
%S2 & Text (.txt) & Script of modelling code used to make Figure X \\
%S3 & Text (.txt) & Raw data from experiment X \\
%S4 & Video (.mp4) & Video demonstrating the hardware in use \\
%... & ... & ... \\
%\bottomrule
%\end{tabularx}
%}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\authorcontributionsu Konseptualizatsiya, X.X. va Y.Y.; metodologiya, X.X.; dasturiy ta'minot, X.X.; tasdiqlash, X.X., Y.Y. va Z.Z.; rasmiy tahlil, X.X.; tadqiqot, X.X.; resurslar, X.X.; ma'lumotlarni kuratorlik qilish, X.X.; original matnni yozish, X.X.; yozish va tahrirlash, X.X.; vizualizatsiya, X.X.; rahbarlik, X.X.; loyiha boshqaruvi, X.X.; moliya jalb qilish, Y.Y. Barcha mualliflar nashr qilingan qo‘lyozma versiyasi bilan tanish va u bilan rozi."

Terminlar haqida tushuntirish uchun \href{http://img.mdpi.org/data/contributor-role-instruction.pdf}{CRediT taksonomiyasiga} murojaat qiling. Mualliflik faqat taqdim etilgan ishga sezilarli hissa qo‘shgan shaxslarga cheklanishi kerak.

\authorcontributions

For research articles with several authors, a short paragraph specifying their individual contributions must be provided. The following statements should be used ``Conceptualization, X.X. and Y.Y.; methodology, X.X.; software, X.X.; validation, X.X., Y.Y. and Z.Z.; formal analysis, X.X.; investigation, X.X.; resources, X.X.; data curation, X.X.; writing---original draft preparation, X.X.; writing---review and editing, X.X.; visualization, X.X.; supervision, X.X.; project administration, X.X.; funding acquisition, Y.Y. All authors have read and agreed to the published version of the manuscript.'', please turn to the  \href{http://img.mdpi.org/data/contributor-role-instruction.pdf}{CRediT taxonomy} for the term explanation. Authorship must be limited to those who have contributed substantially to the work~reported.

\fundingu

{Ishga tashqi moliya ajratilmagan" yoki "Ushbu tadqiqot NAME OF FUNDER nomli grant yordamida moliyalashtirildi, raqam XXX". Shuningdek, "APC XXX tomonidan moliyalashtirildi" degan ma'lumotni qo‘shing. Taqdim etilgan ma'lumotlarning to‘g‘ri ekanligini ehtiyotkorlik bilan tekshiring va moliya fondlarining nomlarini \url{https://search.crossref.org/funding} saytida ko‘rsatilgan standart yozuvlardan foydalanib yozing; har qanday xatolik kelajakdagi moliyaviy qo‘llab-quvvatlashga ta'sir qilishi mumkin.}

\funding

{Please add: ``This research received no external funding'' or ``This research was funded by NAME OF FUNDER grant number XXX.'' and  and ``The APC was funded by XXX''. Check carefully that the details given are accurate and use the standard spelling of funding agency names at \url{https://search.crossref.org/funding}, any errors may affect your future funding.}}

\institutionalreviewu

{Agar tadqiqot institut yoki etik qo‘mita tomonidan tasdiqlashni talab qilgan bo‘lsa, ushbu bo‘limga institut tomonidan tasdiqlash haqidagi bayonotni va tasdiqlash raqamini qo‘shishingiz kerak. Agar tadqiqot etik tasdiqlashni talab qilmagan bo‘lsa, ushbu bayonotni qo‘shishni istamasligingiz mumkin.

Quyidagi ifodalardan birini qo‘shing:

"Tadqiqot Xelsinki Deklaratsiyasiga muvofiq o‘tkazildi va [Institut nomi] tomonidan tasdiqlangan (protokol kodi XXX va tasdiqlash sanasi)."
"Hayvonlar bilan olib borilgan tadqiqot protokoli [Institut nomi] tomonidan tasdiqlangan (protokol kodi XXX va tasdiqlash sanasi)."
"Tadqiqot uchun etik ko‘rib chiqish va tasdiqlash PРИЧИНA (iltimos, batafsil asoslashni taqdim eting) sababli bekor qilindi."
"Mos kelmaydi" (agar tadqiqotda odamlar yoki hayvonlar ishtirok etmagan bo‘lsa).
Tahririy kengash qo‘shimcha ma'lumot talab qilishi mumkinligini esda tuting.}

\institutionalreview

{In this section, you should add the Institutional Review Board Statement and approval number, if relevant to your study. You might choose to exclude this statement if the study did not require ethical approval. Please note that the Editorial Office might ask you for further information. Please add “The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board (or Ethics Committee) of NAME OF INSTITUTE (protocol code XXX and date of approval).” for studies involving humans. OR “The animal study protocol was approved by the Institutional Review Board (or Ethics Committee) of NAME OF INSTITUTE (protocol code XXX and date of approval).” for studies involving animals. OR “Ethical review and approval were waived for this study due to REASON (please provide a detailed justification).” OR “Not applicable” for studies not involving humans or animals}

\informedconsentr

{Inson ishtirokchilari ishtirokidagi tadqiqotlarni tavsiflovchi har qanday ilmiy maqola quyidagi bayonotni o'z ichiga olishi kerak. Iltimos, qo'shing: "Barcha tadqiqot ishtirokchilaridan xabardor qilingan rozilik olindi." YOKI "Bemorning roziligi SABAB tufayli bekor qilindi (iltimos, batafsil asoslab bering)." YOKI insonlar ishtirok etmaydigan tadqiqotlar uchun "qo'llanilmaydi". Agar tadqiqot insonlar ishtirok etmagan bo'lsa, siz ushbu bayonotni chiqarib tashlashni tanlashingiz mumkin. Nashr qilish uchun yozma rozilik identifikatsiya qilinadigan bemorlardan (shu jumladan bemorlarning o'zidan) olinishi kerak. Iltimos, agar kerak bo'lsa, "Ushbu maqolani chop etish uchun bemor(lar)dan yozma ma'lumotli rozilik olingan" ni ko'rsating."}

\informedconsent

{Any research article describing a study involving humans should contain this statement. Please add ``Informed consent was obtained from all subjects involved in the study.'' OR ``Patient consent was waived due to REASON (please provide a detailed justification).'' OR ``Not applicable'' for studies not involving humans. You might also choose to exclude this statement if the study did not involve humans. 
Written informed consent for publication must be obtained from participating patients who can be identified (including by the patients themselves). Please state ``Written informed consent has been obtained from the patient(s) to publish this paper'' if applicable.}

\dataavailabilityr

{Jurnalda chop etilgan maqolalarning barcha mualliflarini tadqiqot ma'lumotlarini baham ko'rishga chorlaymiz. Ushbu bo'limda taqdim etilgan natijalarni tasdiqlovchi ma'lumotlarni, shu jumladan tadqiqot davomida tahlil qilingan yoki yaratilgan ommaviy arxivlangan ma'lumotlar to'plamiga havolalarni qaerdan topish mumkinligini ko'rsating. Agar yangi ma'lumotlar yaratilmagan bo'lsa yoki maxfiylik yoki axloqiy cheklovlar tufayli ma'lumotlar mavjud bo'lmasa, bu haqda bayonot taqdim etilishi kerak.}

\dataavailability

{We encourage all authors of articles published in the journal to share their research data. In this section, please specify where the data supporting the reported results can be found, including links to publicly archived datasets analyzed or generated during the study. If no new data were created or if data is unavailable due to privacy or ethical restrictions, a statement is still required.}

% Only for journal Nursing Reports
%\publicinvolvement{Please describe how the public (patients, consumers, carers) were involved in the research. Consider reporting against the GRIPP2 (Guidance for Reporting Involvement of Patients and the Public) checklist. If the public were not involved in any aspect of the research add: ``No public involvement in any aspect of this research''.}

% Only for journal Nursing Reports
%\guidelinesstandards{Please add a statement indicating which reporting guideline was used when drafting the report. For example, ``This manuscript was drafted against the XXX (the full name of reporting guidelines and citation) for XXX (type of research) research''. A complete list of reporting guidelines can be accessed via the equator network: \url{https://www.equator-network.org/}.}

% Only for journal Nursing Reports
%\useofartificialintelligence{Please describe in detail any and all uses of artificial intelligence (AI) or AI-assisted tools used in the preparation of the manuscript. This may include, but is not limited to, language translation, language editing and grammar, or generating text. Alternatively, please state that “AI or AI-assisted tools were not used in drafting any aspect of this manuscript”.}

%\acknowledgments{Не п.}
\acknowledgmentsr

{Ushbu bo'limda siz muallif hissasi yoki moliyalashtirish bo'limlari qamrab olinmagan har qanday yordamni tan olishingiz mumkin. Bunga ma'muriy va texnik yordam yoki naturadagi xayriyalar (masalan, tajribalar uchun ishlatiladigan materiallar) kiradi.}

\acknowledgments

{In this section you can acknowledge any support given which is not covered by the author contribution or funding sections. This may include administrative and technical support, or donations in kind (e.g., materials used for experiments).}

\conflictsofinterestr

{"Har qanday manfaatlar to'qnashuvini yoki davlatni ko'rsating: "Mualliflar o'zlarining manfaatlar to'qnashuvi yo'qligini e'lon qiladilar." Mualliflar tadqiqot natijalarini taqdim etish yoki talqin qilishga nomaqbul ta'sir ko'rsatadigan har qanday shaxsiy holatlar yoki manfaatlarni aniqlashlari va e'lon qilishlari kerak. Tadqiqotni loyihalashda, ma'lumotlarni yig'ishda, tahlil qilishda yoki sharhlashda, qo'lyozmani yozishda yoki natijalarni nashr etish to'g'risida qaror qabul qilishda moliyachilarning har qanday roli ushbu bo'limda oshkor etilishi kerak. Agar homiylarning roli bo'lmasa, iltimos: “Homiylar tadqiqotni loyihalashda ishtirok etmagan; ma'lumotlarni to'plash, tahlil qilish yoki sharhlashda; qo'lyozmani yozishda yoki natijalarni nashr etish to'g'risida qaror qabul qilishda".} 

\conflictsofinterest

{Declare conflicts of interest or state ``The authors declare no conflicts of interest.'' Authors must identify and declare any personal circumstances or interest that may be perceived as inappropriately influencing the representation or interpretation of reported research results. Any role of the funders in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript; or in the decision to publish the results must be declared in this section. If there is no role, please state ``The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results''.}
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\abbreviations{}

\noindent 
\begin{tabular}{@{}lllllll}
WoS  &  web of science\\
DOAJ & Directory of open access journals\\
TLA & Three letter acronym\\
LD & Linear dichroism
\end{tabular}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% Optional

%% Only for journal Encyclopedia
%\entrylink{The Link to this entry published on the encyclopedia platform.}

%\abbreviations{Abbreviations}{
%В данной рукописи использованы следующие сокращения:\\
%}


%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\reftitle{\textbf{Adabiyot}}

% Please provide either the correct journal abbreviation (e.g. according to the “List of Title Word Abbreviations” http://www.issn.org/services/online-services/access-to-the-ltwa/) or the full name of the journal.
% Citations and References in Supplementary files are permitted provided that they also appear in the reference list here. 

%=====================================
% References, variant A: external bibliography
%=====================================
%\bibliography{your_external_BibTeX_file}

%=====================================
% References, variant B: internal bibliography
%=====================================
\begin{thebibliography}{999}
% Reference 1
\bibitem[Author1(year)]{ref-journal}
Author~1, T. The title of the cited article. {\em Journal Abbreviation} {\bf 2008}, {\em 10}, 142--149.
% Reference 2
\bibitem[Author2(year)]{ref-book1}
Author~2, L. The title of the cited contribution. In {\em The Book Title}; Editor 1, F., Editor 2, A., Eds.; Publishing House: City, Country, 2007; pp. 32--58.
% Reference 3
\bibitem[Author3(year)]{ref-book2}
Author 1, A.; Author 2, B. \textit{Book Title}, 3rd ed.; Publisher: Publisher Location, Country, 2008; pp. 154--196.
% Reference 4
\bibitem[Author4(year)]{ref-unpublish}
Author 1, A.B.; Author 2, C. Title of Unpublished Work. \textit{Abbreviated Journal Name} year, \textit{phrase indicating stage of publication (submitted; accepted; in press)}.
% Reference 5
\bibitem[Author5(year)]{ref-communication}
Author 1, A.B. (University, City, State, Country); Author 2, C. (Institute, City, State, Country). Personal communication, 2012.
% Reference 6
\bibitem[Author6(year)]{ref-proceeding}
Author 1, A.B.; Author 2, C.D.; Author 3, E.F. Title of presentation. In Proceedings of the Name of the Conference, Location of Conference, Country, Date of Conference (Day Month Year); Abstract Number (optional), Pagination (optional).
% Reference 7
\bibitem[Author7(year)]{ref-thesis}
Author 1, A.B. Title of Thesis. Level of Thesis, Degree-Granting University, Location of University, Date of Completion.
% Reference 8
\bibitem[Author8(year)]{ref-url}
Title of Site. Available online: URL (accessed on Day Month Year).\\

\end{thebibliography}


% If authors have biography, please use the format below
%\section*{Short Biography of Authors}
%\bio
%{\raisebox{-0.35cm}{\includegraphics[width=3.5cm,height=5.3cm,clip,keepaspectratio]{Definitions/author1.pdf}}}
%{\textbf{Firstname Lastname} Biography of first author}
%
%\bio
%{\raisebox{-0.35cm}{\includegraphics[width=3.5cm,height=5.3cm,clip,keepaspectratio]{Definitions/author2.jpg}}}
%{\textbf{Firstname Lastname} Biography of second author}

% For the publication.uz journals use author-date citation, please follow the formatting guidelines on http://www.publication.uz/authors/references
% To cite two works by the same author: \citeauthor{ref-journal-1a} (\citeyear{ref-journal-1a}, \citeyear{ref-journal-1b}). This produces: Whittaker (1967, 1975)
% To cite two works by the same author with specific pages: \citeauthor{ref-journal-3a} (\citeyear{ref-journal-3a}, p. 328; \citeyear{ref-journal-3b}, p.475). This produces: Wong (1999, p. 328; 2000, p. 475)

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% for journal Sci
%\reviewreports{\\
%Reviewer 1 comments and authors’ response\\
%Reviewer 2 comments and authors’ response\\
%Reviewer 3 comments and authors’ response
%}
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%\PublishersNote{}


\noindent\textbf{Nashriyot javobgar emas/ eslatmasi:}
Barcha nashrlarda keltirilgan bayonotlar, fikrlar va ma'lumotlar faqat mualliflar va ishtirokchilarga tegishlidir, na Jurnal va na muharrirlar. Jurnal va muharrirlar, mazkur kontentda keltirilgan har qanday g‘oyalar, usullar, ko‘rsatmalar yoki mahsulotlar natijasida insonlar yoki mulkka yetkazilgan har qanday zarar uchun javobgar emas.

\noindent\textbf{Disclaimer of liability/Publisher's Note:} The statements, opinions and data contained in all publications belong exclusively to individuals.The authors and participants, and the Journal and the editors. The journal and the editors are not responsible for any damage caused to people or property resulting from any ideas, methods, instructions or products mentioned in the content.

\end{sloppypar}
\end{document}


 